bluebird bio Inc (NAS:BLUE)
$ 0.9486 -0.0263 (-2.72%) Market Cap: 182.84 Mil Enterprise Value: 315.68 Mil PE Ratio: 0 PB Ratio: 0.45 GF Score: 37/100

bluebird bio Inc Provides Assessment of Impact of COVID-19 - Call Transcript

Mar 26, 2020 / 12:30PM GMT
Release Date Price: $30.15 (-1.58%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the bluebird bio conference call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I would now like to hand the conference over to your speaker today, Ingrid Goldberg. Please go ahead, ma'am.

Ingrid Goldberg
bluebird bio, Inc. - VP of IR

Thank you. Good morning, everyone. This is Ingrid Goldberg, Investor Relations at bluebird bio. Welcome to today's conference call.

Before we begin, I would like to remind you that our discussion today includes forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on our current expectations and assumptions that are subject to risks and uncertainties, and actual results may differ materially from those expressed today due to a variety of factors. Additional information concerning these risk factors is in our filings with the SEC and available on the Investors section of our website at

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot